Cefprozil Anhydrous, (E)-
Who holds supplier records for Cefprozil Anhydrous, (E)-? 6 organisations hold a current record for Cefprozil Anhydrous, (E)-: an active US FDA Type II Drug Master File. A further 7 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (5) and China (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records
Cite as: PharmaTek, “Cefprozil Anhydrous, (E)-: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/cefprozil-anhydrous-e
Reading the evidence
- 6 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
5 of the 6 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 4 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (6)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Cefprozil Anhydrous, (E)-. Country is the organisation's recorded country, not necessarily the manufacturing site.
- APITORIA PHARMA PRIVATE LTDIndia Company GMP cert on recordActive DMF 18469 · latest filing Jun 2005
- COVALENT LABORATORIES PRIVATE LTDIndiaActive DMF 29383 · latest filing May 2015
- Lupin LimitedIndia Company GMP cert on recordActive DMF 17731 · latest filing Sept 2004
- Orchid Pharma LimitedIndia Company GMP cert on recordActive DMF 17375 · latest filing May 2004
- PURE AND CURE HEALTHCARE PRIVATE LTDIndiaActive DMF 24047 · latest filing Aug 2010
- Qilu Antibiotics Pharmaceutical Co., Ltd.China Company GMP cert on recordActive DMF 26699 · latest filing Jan 2013
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (7)
Organisations whose Type II DMFs for Cefprozil Anhydrous, (E)- are no longer active. These show a past filing, not current supply.
Show all 7 historical records
- Italy · Inactive DMF 26354 · filed Aug 2012
- India · Inactive DMF 21471 · filed Mar 2008
- ORCHID CHEMICALS AND PHARMACEUTICALS LTDInactive DMF 18901 · filed Oct 2005
- India · Inactive DMF 18434 · filed Jun 2005
- Teva Pharmaceutical Industries Ltd.Israel · Inactive DMF 17827 · filed Nov 2004
- India · Inactive DMF 17453 · filed Jun 2004
- India · Inactive DMF 16973 · filed Nov 2003
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Cefprozil Anhydrous, (E)- is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL276568).
Chemical identity
- IUPAC name
- (6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(E)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- Canonical SMILES
- C/C=C/C1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)SC1)C(=O)O
- InChIKey
- WDLWHQDACQUCJR-ZAMMOSSLSA-N
- Synonyms
- trans-Cefprozil, CEFPROZIL ANHYDROUS, (E)-, Cefprozil Anhydrous, E-, RefChem:1132252, CHEBI:748004, Procef, Cefprozilum [INN-Latin], Cefprozilo [INN-Spanish], Brisoral, Cefprozil (E)-isomer, E-Cefprozil, Cefprozil Impurity 8
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Cefprozil Anhydrous, (E)-?
6 organisations hold an active US FDA Type II Drug Master File or a CEP for Cefprozil Anhydrous, (E)-: APITORIA PHARMA PRIVATE LTD (India), COVALENT LABORATORIES PRIVATE LTD (India), Lupin Limited (India), Orchid Pharma Limited (India), PURE AND CURE HEALTHCARE PRIVATE LTD (India) and Qilu Antibiotics Pharmaceutical Co., Ltd. (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Cefprozil Anhydrous, (E)- Drug Master Files are active?
APITORIA PHARMA PRIVATE LTD (DMF 18469), COVALENT LABORATORIES PRIVATE LTD (DMF 29383), Lupin Limited (DMF 17731), Orchid Pharma Limited (DMF 17375), PURE AND CURE HEALTHCARE PRIVATE LTD (DMF 24047) and Qilu Antibiotics Pharmaceutical Co., Ltd. (DMF 26699). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Cefprozil Anhydrous, (E)- records mean?
7 organisations have only inactive Type II DMFs for Cefprozil Anhydrous, (E)-. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Cefprozil Anhydrous, (E)- supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Cefprozil Anhydrous, (E)-?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.